Skip to main content
. 2011 Mar 24;55(1):e8. doi: 10.4081/ejh.2011.e8

Table 4. Table of contigency (portio vaginalis uteri carcinoma in situ).

Test Disease present (PVU carcinoma in situ) Disease absent (control group) Total
bcl-2 overexpression 10 (P=0.018) 2 12
bcl-2 negative 12 34 46
Total 22 36 58

PVU, portio vaginalis uteri.